Research programme: steroid-protein conjugates - Medexis

Drug Profile

Research programme: steroid-protein conjugates - Medexis

Alternative Names: CastBSA project; MED-C100; Steroid-protein conjugates research programme - Medexis

Latest Information Update: 04 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medexis
  • Class Albumins; Drug conjugates; Small molecules; Steroids
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Prostate cancer

Most Recent Events

  • 04 Feb 2011 No development reported - Preclinical for Cancer in Greece (unspecified route)
  • 04 Feb 2011 No development reported - Preclinical for Prostate cancer in Greece (unspecified route)
  • 07 May 2010 Pharmacodynamics data from a preclinical study in prostate cancer presented at the 101st Annual Meeting of the American Association for Cancer Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top